Equities
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

On Monday, Bristol-Myers Squibb Co (BRM:BER) closed at 50.54, 16.59% above the 52 week low of 43.35 set on Mar 23, 2020.
52-week range
Today
43.35Mar 23 202059.38May 18 2020
Markit short selling activity
Low
Med
High
Open50.54
High50.54
Low50.54
Bid--
Offer--
Previous close49.46
Average volume4.21k
Shares outstanding2.24bn
Free float2.22bn
P/E (TTM)--
Market cap135.39bn USD
EPS (TTM)-4.02
USD
Annual div (ADY)1.64
EUR
Annual div yield (ADY)3.33%
Div ex-dateJan 04 2021
Div pay-dateFeb 01 2021
Next div ex-dateMar 31 2021
Next div pay-dateMay 03 2021
Data delayed at least 15 minutes, as of Mar 08 2021 07:00 GMT.
More ▼
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.